China Universal Asset Management »

Dyne Therapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Dyne Therapeutics (DYN) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Dyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dyne Therapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dyne Therapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $442k 16k 28.38
2023-12-31 $94k 7.1k 13.24
2023-09-30 $14k 1.6k 8.99
2023-06-30 $9.0k 764 11.78
2023-03-31 $8.0k 706 11.33
2022-12-31 $6.0k 530 11.32
2022-09-30 $6.0k 484 12.40

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding Dyne Therapeutics

Atlas Venture Life Science Advisors
Fcpm Iii Services B.v.
Citadel Advisors
Vanguard Group
VR Adviser
Franklin Resources
Logos Global Management
Vivo Capital
Artal Group
Jennison Associates
Frazier Life Sciences Management
Goldman Sachs Group
Ikarian Capital
Commodore Capital
Dimensional Fund Advisors

View all funds holding Dyne Therapeutics